Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


22.10.2018

1 AIDS
2 Am J Gastroenterol
2 Clin Infect Dis
2 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
3 Gastroenterology
2 Hepatology
1 J Infect Dis
1 J Med Virol
9 J Viral Hepat
2 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. VAN SANTEN DK, van der Helm JJ, Touloumi G, Pantazis N, et al
    Effect of incident hepatitis C infection on CD4 count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002040.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. YEE HS, Burton MJ, Belperio PS, Morgan TR, et al
    The Veterans Affairs Hepatitis C Treatment Considerations.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0231.
    PubMed     Text format    

  3. YIP TC, Chan HL, Tse YK, Lam KL, et al
    On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0247.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  4. TALAL AH, Andrews P, Mcleod A, Chen Y, et al
    Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus (HCV) Management in Opioid Use Disorder Patients on Methadone.
    Clin Infect Dis. 2018 Oct 17. pii: 5133592. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. BRESKIN A, Westreich D, Cole SR, Hudgens MG, et al
    The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2018 Oct 12. pii: 5128783. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  6. AHN SH, Marcellin P, Ma X, Caruntu FA, et al
    Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
    Dig Dis Sci. 2018 Oct 15. pii: 10.1007/s10620-018-5294.
    PubMed     Text format     Abstract available

  7. LIEW ZH, Goh GB, Hao Y, Chang PE, et al
    Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5331.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  8. KRUGER K, Krauth C, Rossol S, Mauss S, et al
    Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-registry.
    Eur J Gastroenterol Hepatol. 2018 Oct 15. doi: 10.1097/MEG.0000000000001283.
    PubMed     Text format     Abstract available


    Gastroenterology

  9. DELTENRE P, Marot A, Moreno C
    Outcomes after early liver transplantation for patients with severe alcoholic hepatitis: Additional evidence from a meta-analysis.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35151.
    PubMed     Text format    

  10. VISENTINI M, Fiorilli M, Casato M
    Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35150.
    PubMed     Text format    

  11. SOLGA SF, Goldberg DS, Spacek LA, Forde KA, et al
    Comment on B Lee et al Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35153.
    PubMed     Text format    


    Hepatology

  12. CHEN Y, Hao X, Sun R, Wei H, et al
    NK cell-derived IFN-gamma promotes hepatocellular carcinoma through EpCAM-EMT axis in hepatitis B virus transgenic mice.
    Hepatology. 2018 Oct 17. doi: 10.1002/hep.30317.
    PubMed     Text format     Abstract available

  13. ROSENTHAL P, Ling SC, Belle SH, Murray KF, et al
    Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection.
    Hepatology. 2018 Oct 15. doi: 10.1002/hep.30312.
    PubMed     Text format     Abstract available


    J Infect Dis

  14. CHOI Y, Zhang X, Skinner B
    Analysis of IgG anti-HEV antibody protective levels during hepatitis E virus reinfection in experimentally infected rhesus macaques.
    J Infect Dis. 2018 Oct 16. pii: 5132976. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  15. YUGO DM, Cossaboom CM, Heffron CL, Huang YW, et al
    Evidence for an Unknown Agent Antigenically Related to the Hepatitis E Virus in Dairy Cows in the United States.
    J Med Virol. 2018 Oct 14. doi: 10.1002/jmv.25339.
    PubMed     Text format     Abstract available


    J Viral Hepat

  16. XIANG-CHUN D, Xiao-Qing Y, Ting-Ting Y, Zhen-Hui L, et al
    Alpha-enolase regulates hepatitis B virus replication through suppression of the interferon signalling pathway.
    J Viral Hepat. 2018;25:289-295.
    PubMed     Text format     Abstract available

  17. YUE X, Ge C, Zhuge S, He H, et al
    Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: A hospital-based study.
    J Viral Hepat. 2018;25:373-380.
    PubMed     Text format     Abstract available

  18. DINESHA TR, Boobalan J, Sivamalar S, Subashini D, et al
    Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV.
    J Viral Hepat. 2018;25:718-723.
    PubMed     Text format     Abstract available

  19. JAYASUNDARA D, Hui BB, Regan DG, Heywood AE, et al
    Modelling the decline and future of hepatitis A transmission in Australia.
    J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13018.
    PubMed     Text format     Abstract available

  20. MCLEOD A, Weir A, Hutchinson SJ, Goldberg DJ, et al
    Hepatitis C test uptake among historic blood transfusion recipients following media coverage of the Penrose Inquiry and an awareness-raising campaign.
    J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13016.
    PubMed     Text format     Abstract available

  21. ASGARI S, Chaturvedi N, Scepanovic P, Hammer C, et al
    Human genomics of acute liver failure due to hepatitis B virus infection: an exome sequencing study in liver transplant recipients.
    J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13019.
    PubMed     Text format     Abstract available

  22. GOUTZAMANIS S, Doyle J, Higgs P, Hellard M, et al
    Improving hepatitis C direct-acting antiviral access and uptake: a role for patient-reported outcomes and lived-experience.
    J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13020.
    PubMed     Text format     Abstract available

  23. MOREY S, Hamoodi A, Jones D, Young T, et al
    Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
    J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13017.
    PubMed     Text format     Abstract available

  24. KNOP V, Hofmann WP, Buggisch P, Klinker H, et al
    Estimation of liver fibrosis by non-commercial serum markers in comparison to transient elastography in patients with chronic hepatitis C virus infection receiving direct acting antiviral treatment.
    J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13021.
    PubMed     Text format     Abstract available


    PLoS One

  25. MCCLURE MW, Berliba E, Tsertsvadze T, Streinu-Cercel A, et al
    Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
    PLoS One. 2018;13:e0204974.
    PubMed     Text format     Abstract available

  26. NISBET AI, Omuse G, Revathi G, Adam RD, et al
    Seroprevalence data at a private teaching hospital in Kenya: An examination of Toxoplasma gondii, cytomegalovirus, rubella, hepatitis A, and Entamoeba histolytica.
    PLoS One. 2018;13:e0204867.
    PubMed     Text format     Abstract available


    Vaccine

  27. SAITOH A, Okabe N
    Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap".
    Vaccine. 2018;36:4582-4588.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: